Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Combined with Formoterol and Tiotropium for ACO
NCT03504527Unknown
- Sponsor
- Huashan Hospital
- Start
- May 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of budesonide in Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS) (2 arms), sponsored by Huashan Hospital. Primary endpoint: Frequency of ACO exacerbation at 12 months. Status: unknown.
02
Drugs
budesonide
03
Conditions
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS)
Beyond the preview
Go deeper on NCT03504527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03504527.